← Back to Clinical Trials
Recruiting NCT07842224

NCT07842224 The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07842224
Status Recruiting
Phase —
Sponsor Summit Institute for Development, Indonesia
Condition Digital Health
Study Type INTERVENTIONAL
Enrollment 10,800 participants
Start Date 2026-10
Primary Completion 2027-05

Eligibility & Interventions

Sex Female only
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Digitally Enabled District (DED)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10,800 participants in total. It began in 2026-10 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

DED 2.0 is a stepped-wedge cluster-randomized trial testing whether an integrated digital health ecosystem (KuApps, a service-monitoring dashboard, AI-assisted OCR for handwritten records, two-way WhatsApp-based health communication, and an automated worker-support tool) improves the completeness and timeliness of maternal and neonatal primary health care services, delivered through 45 Puskesmas in Garut Regency, West Java, Indonesia.

Eligibility Criteria

Inclusion Criteria (Pregnant Women): * Mothers residing within the catchment area of a participating Puskesmas in Garut Regency during their pregnancy * Pregnancy registered in the maternal health records of a participating Puskesmas within the study catchment area in Garut Regency * The pregnant woman provides informed consent to participate in the study. Exclusion Criteria (Pregnant Women): \- The participant relocates permanently outside the study area before the outcome-observation window begins. Inclusion Criteria (Puskesmas Level): \- Located in Garut Regency; at baseline, the DED ecosystem had not been integrated into daily service operations. Exclusion Criteria (Puskesmas Level): * Puskesmas had fully implemented the DED ecosystem in daily practice before the study baseline period * Puskesmas lacks adequate routine service data for outcome measurement throughout the study period

Contact & Investigator

Central Contact

Yuni Dwi Setiyawati, B.Nutr, MHID, Dietitian, Master's degree

✉ yuni.setiyawati@sid-indonesia.org

📞 +6285337006810

Principal Investigator

Yuni Dwi Setiyawati, B.Nutr, MHID, Dietitian

PRINCIPAL INVESTIGATOR

Summit Institute for Development

Frequently Asked Questions

Who can join the NCT07842224 clinical trial?

This trial is open to female participants only, studying Digital Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07842224 currently recruiting?

Yes, NCT07842224 is actively recruiting participants. Contact the research team at yuni.setiyawati@sid-indonesia.org for enrollment information.

Where is the NCT07842224 trial being conducted?

This trial is being conducted at Mataram, Indonesia.

Who is sponsoring the NCT07842224 clinical trial?

NCT07842224 is sponsored by Summit Institute for Development, Indonesia. The principal investigator is Yuni Dwi Setiyawati, B.Nutr, MHID, Dietitian at Summit Institute for Development. The trial plans to enroll 10,800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology